Showcasing Pharmaceutical Excipients and APIs and Connecting with Global Industry Partners
Xi’an DELI Biochemical Industry Co., Ltd. has successfully concluded its participation in CPHI Milan 2026, an international exhibition serving the pharmaceutical ingredients and pharmaceutical manufacturing industries. The event provided an opportunity for DELI to present its product portfolio, meet with industry professionals, and exchange information with customers and potential business partners from different markets.
During the exhibition, the DELI team welcomed visitors at its booth, introduced the company’s key pharmaceutical excipients and active pharmaceutical ingredients (APIs), and engaged in face-to-face discussions about product specifications, quality requirements, and customer needs.
Participation in CPHI Milan was also an opportunity to strengthen professional connections and gain a better understanding of the requirements of the international pharmaceutical market.
Highlights from the DELI team’s participation in CPHI Milan 2026.
The video captures moments from the exhibition and offers a closer look at the DELI team’s participation, product introductions, and interactions with visitors. These in-person exchanges are an important part of maintaining customer relationships, understanding market needs, and exploring opportunities for future cooperation.
Pharmaceutical excipients are an important part of Xi’an DELI Biochemical Industry Co., Ltd.’s product portfolio. At CPHI Milan 2026, the company highlighted two key products: Hydroxypropyl Betadex and Betadex Sulfobutyl Ether Sodium.
Hydroxypropyl Betadex is a cyclodextrin-based pharmaceutical excipient used in pharmaceutical formulation development. Depending on the active ingredient and formulation, it can help improve drug solubility and support the development of suitable pharmaceutical formulations.
At the exhibition, DELI introduced this product to visitors and exchanged information on product specifications, quality requirements, and potential pharmaceutical applications. These discussions helped the team better understand customer expectations and identify areas for further technical and commercial communication.
Betadex Sulfobutyl Ether Sodium is another core pharmaceutical excipient in DELI’s portfolio. This modified cyclodextrin is used in pharmaceutical formulations, including certain injectable drug products, to support the solubilization of active pharmaceutical ingredients.
Through product introductions and face-to-face discussions, the DELI team had opportunities to communicate with visitors about product requirements, intended applications, and potential cooperation. The company continues to focus on serving pharmaceutical customers with relevant product information and professional support.
In addition to its core pharmaceutical excipients, Xi’an DELI Biochemical Industry Co., Ltd. also highlighted two active pharmaceutical ingredients: Glucosamine Sulfate and Menatetrenone (Vitamin K2).
Glucosamine Sulfate is an active ingredient used in pharmaceutical and related formulations, depending on the product and applicable market requirements. At CPHI Milan, DELI introduced this product as part of its broader portfolio and exchanged information with visitors regarding product specifications and customer requirements.
Menatetrenone, also known as Vitamin K2, is another product in the company’s API portfolio. The exhibition provided an opportunity to introduce the product to industry professionals and discuss relevant product information and potential business needs.
By presenting these APIs alongside its core pharmaceutical excipients, DELI aimed to provide visitors with a clearer understanding of its product range and support further communication with prospective customers.
Face-to-face communication remains valuable in international pharmaceutical business. It allows companies and customers to discuss specific requirements, clarify product information, and develop a better understanding of potential cooperation.
Throughout CPHI Milan 2026, the DELI team engaged with visitors at its booth, listened to customer inquiries, and exchanged information about its products and services. These conversations provided opportunities to understand different market needs and maintain communication with existing and prospective business partners.
For Xi’an DELI Biochemical Industry Co., Ltd., participation in international exhibitions is not only an opportunity to showcase products but also a way to strengthen relationships, learn from industry professionals, and stay connected with developments across the pharmaceutical supply chain.
Xi’an DELI Biochemical Industry Co., Ltd. is committed to developing its pharmaceutical ingredients business and maintaining a customer-focused approach. The company recognizes the importance of consistent product quality, clear communication, and responsive service in supporting long-term business relationships.
The experience gained at CPHI Milan will contribute to the company’s continued efforts to understand customer needs, improve communication with international partners, and explore opportunities for future cooperation.
We would like to thank everyone who visited our booth and took the time to meet with our team during CPHI Milan 2026. We appreciate your interest in Xi’an DELI Biochemical Industry Co., Ltd. and our product portfolio.
Although the exhibition has concluded, we welcome continued communication with pharmaceutical manufacturers, distributors, sourcing professionals, and other industry partners interested in our products.
For more information about Hydroxypropyl Betadex, Betadex Sulfobutyl Ether Sodium, Glucosamine Sulfate, and Menatetrenone (Vitamin K2), please contact our team.
Xi’an DELI Biochemical Industry Co., Ltd. looks forward to continuing conversations with partners worldwide and exploring opportunities for long-term cooperation.
Thank you for connecting with us at CPHI Milan 2026. We look forward to meeting you again at future industry events.
